Pricing Log in Create free account

Anteris Technologies Global Corp. (AVR) vs NeuroPace, Inc. (NPCE)

Anteris Technologies Global Corp. and NeuroPace, Inc. are both Medical Devices companies. Anteris Technologies Global Corp. is the larger, with a market value of $544.0M against $435.6M — 1.2× the size. NeuroPace, Inc. grew revenue faster over the last twelve months: 11.6% against −9.56%. NeuroPace, Inc. has the higher net margin (−19.3% vs −4,619.3%) and the lower return on invested capital (−44.6% vs 0.00%). Across the 17 metrics below, NeuroPace, Inc. leads on 10 and Anteris Technologies Global Corp. on 7.

Valuation

Metric AVR NPCE Medical Devices median
P/E n/m n/m 25.58
P/S 242.70 4.35 2.54
P/B 2.16 36.22 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 128.10 4.47 2.72
Earnings yield (34.88%) (4.52%) (12.82%)
Free cash flow yield (16.22%) (2.70%) (8.18%)

Profitability

Metric AVR NPCE Medical Devices median
Gross margin 74.98% 81.57% 57.76%
Operating margin (4,738.36%) (13.87%) (15.07%)
Net margin (4,619.27%) (19.34%) (14.45%)
Free cash flow margin (3,937.07%) (11.75%) (3.88%)
Return on equity (75.13%) (122.05%) (10.35%)
Return on assets (66.31%) (18.82%) (17.26%)
Return on invested capital 0.00% (44.64%) (5.27%)

Growth

Metric AVR NPCE Medical Devices median
Revenue growth (TTM) (9.56%) 11.59% 10.41%
EPS growth (last fiscal year) 30.71% 29.03% 28.17%
Revenue growth, 5-year CAGR — 19.44% 15.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AVR NPCE Medical Devices median
Debt to equity 0.00 4.97 0.04
Current ratio 14.20 4.94 2.74
Net debt to EBITDA 0.14 0.15 0.54

Dividend

Metric AVR NPCE Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric AVR NPCE Medical Devices median
Market cap 544.01m 435.58m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack